• Policy & Insight

7 images that defined cancer policy in 2022

This year, we’ve accomplished a lot in cancer policy and campaigning. From research and prevention to diagnosis, we’ve been advocating for change to beat cancer. Here are some highlights. This year, we’ve accomplished a lot in cancer policy and campaigning. From research and prevention to diagnosis, we’ve been advocating for change to beat cancer. Here are some highlights.

27 December 2022

• Health & Medicine

Early cancer diagnosis and COVID-19: unpicking the impact of the pandemic

Cancer diagnosis was clearly hit hard by the pandemic, but the data tells a complicated story. What does it mean for the future? Cancer diagnosis was clearly hit hard by the pandemic, but the data tells a complicated story. What does it mean for the future?

20 December 2022

• Health & Medicine

20 years on: how we've decreased cancer death rates

Overall, cancer death rates have decreased by 16% in the UK since we were founded. For our 20th anniversary, we're looking back at the influence and involvement we've had in reducing cancer death rates. Overall, cancer death rates have decreased by 16% in the UK since we were founded. For our 20th anniversary, we're looking back at the influence and involvement we've had in reducing cancer death rates.

17 December 2022

• Personal Stories

From athlete to wig-maker: how cancer changed Maria's destiny

In 2008, Maria was diagnosed with osteosarcoma. In 2019, she started her online wig making business, which has gone on to provide wigs for up to a hundred women who have lost their hair during chemotherapy treatment. In 2008, Maria was diagnosed with osteosarcoma. In 2019, she started her online wig making business, which has gone on to provide wigs for up to a hundred women who have lost their hair during chemotherapy treatment.

16 December 2022

• For Researchers

The power of partnership – the unique alliance taking on brain cancer

The Antibody Alliance Laboratory – a collaboration between Cancer Research UK and AstraZeneca – combines academic rigour with agile bioengineering to push forward antibody discovery projects... The Antibody Alliance Laboratory – a collaboration between Cancer Research UK and AstraZeneca – combines academic rigour with agile bioengineering to push forward antibody discovery projects...

15 December 2022

• Health & Medicine
• Policy & Insight

Junk food marketing restrictions: so near and yet so far

Malcolm Clark, Senior Prevention Policy Manager, gives an insight into Cancer Research UK’s cancer prevention work and the recent government decision on junk food marketing. Malcolm Clark, Senior Prevention Policy Manager, gives an insight into Cancer Research UK’s cancer prevention work and the recent government decision on junk food marketing.

15 December 2022

• Health & Medicine
• Science & Technology

Our most important cancer research stories of 2022

This year has been full of research, advances and people worth celebrating. Here are some of our biggest stories from the past 12 months.  This year has been full of research, advances and people worth celebrating. Here are some of our biggest stories from the past 12 months. 

14 December 2022

• Science & Technology

The future of research: meet three of our scientists working on TRACERx

We chatted to three researchers working on TRACERx, Dr Emilia Lim, Dr William Hill and Emma Colliver about their work, what a day in their lives looks like, and how their paths have led to where they are today.  We chatted to three researchers working on TRACERx, Dr Emilia Lim, Dr William Hill and Emma Colliver about their work, what a day in their lives looks like, and how their paths have led to where they are today. 

13 December 2022

• For Supporters

The Taylor Family Foundation gives £2.1m to support head and neck cancer research

12 December 2022

• Health & Medicine
• Policy & Insight

The 10-year cancer plan: is improving cancer survival still a priority for this Government?  

Cancer is a fixable problem – but we need the right leadership, a robust plan and sufficient funding, writes Michelle Mitchell, our chief executive officer. Cancer is a fixable problem – but we need the right leadership, a robust plan and sufficient funding, writes Michelle Mitchell, our chief executive officer.

8 December 2022

• Health & Medicine
• Charity News

20 years of Cancer Research UK: Celebrating our research nurses

As part of our 20th anniversary we're celebrating our research nurses, who play a vital role in making sure patients are safe and cared for in clinical trials. As part of our 20th anniversary we're celebrating our research nurses, who play a vital role in making sure patients are safe and cared for in clinical trials.

7 December 2022